Table 3.
Finding on clinical and ultrasonographic examinations and specific diagnosis using standard definition
| Finding | Number of women/total | % | |
|---|---|---|---|
| Body mass index | < 18 kg/m2 | 26/1117 | 2.3 |
| 18-25 kg/m2 | 390/1117 | 34.9 | |
| 25-30 kg/m2 | 426/1117 | 38.2 | |
| > 30 kg/m2 | 275/1117 | 24.6 | |
|
Inspecting perineum |
Inflammation | 98/967 | 10.1 |
| Purulent vaginal discharge | 159/967 | 16.4 | |
| Ulcer | 5/967 | 0.5 | |
| Wart | 2/967 | 0.2 | |
| Speculum examination | Mucopurulent cervical discharge | 169/967 | 17.5 |
| Cervix bleed on touching | 32/967 | 3.3 | |
| Cervical inflammation | 107/967 | 11.1 | |
| Cervical laceration | 43/967 | 4.4 | |
| Cervical polyp | 6/967 | 0.6 | |
| *Reproductive tract infections | Using specific definition | 364/967 | 37.6%(95% CI 34.5-40.7) |
| Pelvic organ prolapse | Stage 1 | 296/967 | 30.6 |
| Stage 2 | 77/967 | 8.0 | |
| Sage 3 | 24/967 | 2.5 | |
| Stage 4 | 3/967 | 0.3 | |
| **Total Pelvic organ prolapse | Using specific definition | 391/967 | 41.4(95% CI 39.8- 44.5) |
| Bimanual pelvic examination | Cervical motion tenderness | 60/967 | 6.2 |
| Uterus enlarged | 42/967 | 4.3 | |
| Uterine fibroid | 9/967 | 0.9 | |
| Adnexal mass | 21/967 | 2.2 | |
| Total Pelvic mass correctly diagnosed | 14/929 | 1.5(95% CI 0.7-2.3) | |
| Ultrasonographic findings | Uterus enlarged | 108/929 | 11.2 |
| Endometrial Polyp | 4/929 | 0.4 | |
| Polycystic ovaries | 156/929 | 16.8 | |
| Uterine fibroid | 33/929 | 3.6 | |
| Adnexal mass | 38/929 | 4.1 | |
| Total Pelvic mass | 71/929 | 7.6(95% CI: 5.9-9.3) |